Literature DB >> 20339931

Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors.

Nicholas F Marko1, Amir H Hamrahian, Robert J Weil.   

Abstract

Accurate assessment of the hypothalamic-pituitary-adrenal (HPA) axis is critical for the appropriate management of patients with pituitary adenoma after transsphenoidal surgery. We examine the role of immediate postoperative cortisol levels to assess hypothalamic-pituitary-adrenal axis (HPA) axis function post-operatively. We performed preoperative cortrosyn stimulation test (CST) and measured immediate postoperative serum cortisol levels in 100 patients undergoing 104 transsphenoidal surgeries. These results were compared to those of the CST at 4-6 weeks postoperatively, which served as a measure of HPA axis function. The ability of immediate postoperative, day of surgery (DOS) cortisol levels to predict normal HPA axis function was determined using standard predictive analytic methods and confusion matrix calculations. We found that postoperative, DOS cortisol level > or =15 microg/dL is a sensitive and accurate predictors of normal postoperative HPA axis function, with a sensitivity of 98%, an accuracy of 97%, and a positive predictive value of 99%. Our data suggest that an immediate, postoperative, DOS cortisol level > or =15 microg/dL predicts distant, normal, post-operative HPA axis function following transsphenoidal surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339931     DOI: 10.1007/s11102-010-0227-6

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  27 in total

1.  A RAPID TEST OF ADRENOCORTICAL FUNCTION.

Authors:  J B WOOD; A W FRANKLAND; V H JAMES; J LANDON
Journal:  Lancet       Date:  1965-01-30       Impact factor: 79.321

2.  Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test.

Authors:  G Dickstein; C Shechner; W E Nicholson; I Rosner; Z Shen-Orr; F Adawi; M Lahav
Journal:  J Clin Endocrinol Metab       Date:  1991-04       Impact factor: 5.958

3.  Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease.

Authors:  J Mayenknecht; S Diederich; V Bähr; U Plöckinger; W Oelkers
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

4.  Evaluation of the pituitary-adrenal axis before, during and after pituitary adenomectomy. Is perioperative glucocorticoid therapy necessary?

Authors:  P P García-Luna; A Leal-Cerro; J L Rocha; F Trujillo; F Garcia-Pesquera; R Astorga
Journal:  Acta Endocrinol (Copenh)       Date:  1990-01

Review 5.  Dose-response aspects in the clinical assessment of the hypothalamo-pituitary-adrenal axis, and the low-dose adrenocorticotropin test.

Authors:  W Oelkers
Journal:  Eur J Endocrinol       Date:  1996-07       Impact factor: 6.664

Review 6.  Diagnosis of adrenal insufficiency.

Authors:  Richard I Dorin; Clifford R Qualls; Lawrence M Crapo
Journal:  Ann Intern Med       Date:  2003-08-05       Impact factor: 25.391

Review 7.  Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management.

Authors:  Warrick J Inder; Penny J Hunt
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

8.  Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.

Authors:  Nicholas F Marko; Vivek A Gonugunta; Amir H Hamrahian; Ali Usmani; Marc R Mayberg; Robert J Weil
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

Review 9.  Adrenal insufficiency in critical illness.

Authors:  Mark Stuart Cooper; Paul Michael Stewart
Journal:  J Intensive Care Med       Date:  2007 Nov-Dec       Impact factor: 3.510

10.  Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary.

Authors:  John M Wentworth; Nicole Gao; Kalpana P Sumithran; Niki F Maartens; Andrew H Kaye; Peter G Colman; Peter R Ebeling
Journal:  Clin Endocrinol (Oxf)       Date:  2008-01       Impact factor: 3.478

View more
  11 in total

Review 1.  Current best practice in the management of patients after pituitary surgery.

Authors:  Alessandro Prete; Salvatore Maria Corsello; Roberto Salvatori
Journal:  Ther Adv Endocrinol Metab       Date:  2017-03-01       Impact factor: 3.565

2.  Perioperative Outcomes of a Hydrocortisone Protocol after Endonasal Surgery for Pituitary Adenoma Resection.

Authors:  Tyler D Alexander; Sarah Collopy; Siyuan Yu; Michael Karsy; Chandala Chitguppi; Christopher J Farrell; James J Evans
Journal:  J Neurol Surg B Skull Base       Date:  2021-09-27

Review 3.  Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis.

Authors:  Zuleyha Karaca; Ashley Grossman; Fahrettin Kelestimur
Journal:  Rev Endocr Metab Disord       Date:  2021-03-26       Impact factor: 6.514

Review 4.  Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis.

Authors:  Mamatemin Tohti; Junyang Li; Yuan Zhou; Yuebing Hu; Zhuang Yu; Chiyuan Ma
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

5.  Recovery Room Cortisol Predicts Long-Term Glucocorticoid Need After Transsphenoidal Surgery for Pituitary Tumors.

Authors:  Amro Qaddoura; Tenzin N Shalung; Michael P Meier; Jeannette Goguen; Rowan Jing; Stanley Zhang; Kalman Kovacs; Michael D Cusimano
Journal:  Neurosurgery       Date:  2019-03-01       Impact factor: 4.654

6.  Evaluation of different hydrocortisone treatment strategies in transsphenoidal pituitary surgery.

Authors:  Ola Fridman-Bengtsson; Charlotte Höybye; Laura Porthén; Pär Stjärne; Anna-Lena Hulting; Ola Sunnergren
Journal:  Acta Neurochir (Wien)       Date:  2019-05-07       Impact factor: 2.216

7.  Early postoperative HPA-axis testing after pituitary tumor surgery: reliability and safety of basal cortisol and CRH test.

Authors:  Friso de Vries; Daniel J Lobatto; Leontine E H Bakker; Wouter R van Furth; Nienke R Biermasz; Alberto M Pereira
Journal:  Endocrine       Date:  2019-09-25       Impact factor: 3.633

8.  Selective use of peri-operative steroids in pituitary tumor surgery: escape from dogma.

Authors:  Jacqueline Regan; Joseph Watson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-18       Impact factor: 5.555

9.  Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma.

Authors:  Henrik Borg; Peter Siesjö; Babar Kahlon; Sigridur Fjalldal; Eva Marie Erfurth
Journal:  Endocrine       Date:  2018-07-02       Impact factor: 3.633

10.  Postoperative day 1 versus postoperative day 5 morning cortisol for predicting an intact hypothalamic-pituitary axis: A cohort analysis.

Authors:  Esther Dupepe; Daxa Patel; Joseph Miller; Ivania Rizo; Tom Brooks Vaughan; Kristen Riley
Journal:  Surg Neurol Int       Date:  2019-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.